Gene · 2268
Papers1,862
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 1,862
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Monomeric C-reactive protein via endothelial CD31 for neurovascular inflammation in an ApoE genotype-dependent pattern: A risk factor for Alzheimer's disease? | Aging Cell | 2021 | 34687487 | PubTator, text mining | PubMed |
| Prenatal Exome Sequencing in Recurrent Fetal Structural Anomalies: Systematic Review and Meta-Analysis. | J Clin Med | 2021 | 34682862 | PubTator, text mining | PubMed |
| What Do We Know about Classical and Non-Classical Progesterone Receptors in the Human Female Reproductive Tract? A Review. | Int J Mol Sci | 2021 | 34681937 | PubTator, text mining | PubMed |
| Multiparameter Evaluation of the Platelet-Inhibitory Effects of Tyrosine Kinase Inhibitors Used for Cancer Treatment. | Int J Mol Sci | 2021 | 34681859 | PubTator, text mining | PubMed |
| Signaling Pathways That Regulate Normal and Aberrant Red Blood Cell Development. | Genes (Basel) | 2021 | 34681039 | PubTator, text mining | PubMed |
| CK2 Regulation: Perspectives in 2021. | Biomedicines | 2021 | 34680478 | PubTator, text mining | PubMed |
| HCC and Molecular Targeting Therapies: Back to the Future. | Biomedicines | 2021 | 34680462 | PubTator, text mining | PubMed |
| Oncomine™ Comprehensive Assay v3 vs. Oncomine™ Comprehensive Assay Plus. | Cancers (Basel) | 2021 | 34680378 | PubTator, text mining | PubMed |
| Crosstalk between KRAS, SRC and YAP Signaling in Pancreatic Cancer: Interactions Leading to Aggressive Disease and Drug Resistance. | Cancers (Basel) | 2021 | 34680275 | PubTator, text mining | PubMed |
| Characterization of Phosphorylation Status and Kinase Activity of Src Family Kinases Expressed in Cell-Based and Cell-Free Protein Expression Systems. | Biomolecules | 2021 | 34680080 | PubTator, text mining | PubMed |
| The FGFR Family Inhibitor AZD4547 Exerts an Antitumor Effect in Ovarian Cancer Cells. | Int J Mol Sci | 2021 | 34639155 | PubTator, text mining | PubMed |
| Tau and Membranes: Interactions That Promote Folding and Condensation. | Front Cell Dev Biol | 2021 | 34621743 | PubTator, text mining | PubMed |
| Bruton's Tyrosine Kinase Inhibition as an Emerging Therapy in Systemic Autoimmune Disease. | Drugs | 2021 | 34609725 | PubTator, text mining | PubMed |
| Preclinical development of a bispecific TNFα/IL-23 neutralising domain antibody as a novel oral treatment for inflammatory bowel disease. | Sci Rep | 2021 | 34593832 | PubTator, text mining | PubMed |
| Targeting thymidine phosphorylase as a potential therapy for bone loss associated with periprosthetic osteolysis. | Bioeng Transl Med | 2021 | 34589604 | PubTator, text mining | PubMed |
| Examining the Developmental Trajectory of an in Vitro Model of Mouse Primordial Germ Cells following Exposure to Environmentally Relevant Bisphenol A Levels. | Environ Health Perspect | 2021 | 34585602 | PubTator, text mining | PubMed |
| Combination Therapy of Navitoclax with Chemotherapeutic Agents in Solid Tumors and Blood Cancer: A Review of Current Evidence. | Pharmaceutics | 2021 | 34575429 | PubTator, text mining | PubMed |
| Role of Small Molecule Targeted Compounds in Cancer: Progress, Opportunities, and Challenges. | Front Cell Dev Biol | 2021 | 34568317 | PubTator, text mining | PubMed |
| Molecular Mechanism and Pathways of Normal Human Parturition in Different Gestational Tissues: A Systematic Review of Transcriptome Studies. | Front Physiol | 2021 | 34566691 | PubTator, text mining | PubMed |
| Comparison of the transcriptome in circulating leukocytes in early lactation between primiparous and multiparous cows provides evidence for age-related changes. | BMC Genomics | 2021 | 34563126 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2268/papers?page=23